Group One Trading, L.P. Travere Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 12,369 shares of TVTX stock, worth $190,482. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,369
Previous 16,510
25.08%
Holding current value
$190,482
Previous $287,000
23.0%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
238Shares Held
101MCall Options Held
1.79MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$137 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$118 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$116 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$77.2 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$73.9 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $988M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...